Logo image of FOXX

FOXX DEVELOPMENT HOLDINGS IN (FOXX) Stock Fundamental Analysis

NASDAQ:FOXX - Nasdaq - US3516651045 - Common Stock - Currency: USD

5.15  -0.31 (-5.68%)

After market: 4.85 -0.3 (-5.83%)

Fundamental Rating

1

Overall FOXX gets a fundamental rating of 1 out of 10. We evaluated FOXX against 32 industry peers in the Technology Hardware, Storage & Peripherals industry. FOXX may be in some trouble as it scores bad on both profitability and health. FOXX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year FOXX was profitable.
In the past year FOXX has reported a negative cash flow from operations.
FOXX Yearly Net Income VS EBIT VS OCF VS FCFFOXX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 500K -500K

1.2 Ratios

The Return On Assets of FOXX (1.35%) is comparable to the rest of the industry.
The Return On Equity of FOXX (1.85%) is better than 61.29% of its industry peers.
Industry RankSector Rank
ROA 1.35%
ROE 1.85%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FOXX Yearly ROA, ROE, ROICFOXX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 1 -1 2

1.3 Margins

FOXX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FOXX Yearly Profit, Operating, Gross MarginsFOXX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

3

2. Health

2.1 Basic Checks

The number of shares outstanding for FOXX has been reduced compared to 1 year ago.
FOXX has a worse debt/assets ratio than last year.
FOXX Yearly Shares OutstandingFOXX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2M 4M 6M 8M 10M
FOXX Yearly Total Debt VS Total AssetsFOXX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 3.16 indicates that FOXX is not in any danger for bankruptcy at the moment.
FOXX's Altman-Z score of 3.16 is fine compared to the rest of the industry. FOXX outperforms 74.19% of its industry peers.
A Debt/Equity ratio of 0.16 indicates that FOXX is not too dependend on debt financing.
FOXX has a Debt to Equity ratio of 0.16. This is in the better half of the industry: FOXX outperforms 67.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 3.16
ROIC/WACCN/A
WACCN/A
FOXX Yearly LT Debt VS Equity VS FCFFOXX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

FOXX has a Current Ratio of 0.02. This is a bad value and indicates that FOXX is not financially healthy enough and could expect problems in meeting its short term obligations.
FOXX has a Current ratio of 0.02. This is amonst the worse of the industry: FOXX underperforms 96.77% of its industry peers.
FOXX has a Quick Ratio of 0.02. This is a bad value and indicates that FOXX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.02, FOXX is not doing good in the industry: 96.77% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
FOXX Yearly Current Assets VS Current LiabilitesFOXX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 500K 1M 1.5M 2M 2.5M

0

3. Growth

3.1 Past

The earnings per share for FOXX have decreased strongly by -50.44% in the last year.
EPS 1Y (TTM)-50.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-368%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FOXX Yearly Revenue VS EstimatesFOXX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023
FOXX Yearly EPS VS EstimatesFOXX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 128.75, which means the current valuation is very expensive for FOXX.
FOXX's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 29.98. FOXX is valued rather expensively when compared to this.
Industry RankSector Rank
PE 128.75
Fwd PE N/A
FOXX Price Earnings VS Forward Price EarningsFOXX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FOXX Per share dataFOXX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

FOXX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

FOXX DEVELOPMENT HOLDINGS IN

NASDAQ:FOXX (2/28/2025, 8:00:00 PM)

After market: 4.85 -0.3 (-5.83%)

5.15

-0.31 (-5.68%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.6%
Inst Owner Change-91.61%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap37.49M
AnalystsN/A
Price TargetN/A
Short Float %18.03%
Short Ratio0.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 128.75
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.42
P/tB 2.42
EV/EBITDA N/A
EPS(TTM)0.04
EY0.78%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS0
BVpS2.13
TBVpS2.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.35%
ROE 1.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z 3.16
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-368%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-14.86%
OCF growth 3YN/A
OCF growth 5YN/A